白细胞介素-2用于癌症治疗：免疫调控可介导人类癌症的消退。 - Suppr

Suppr

超能文献

Cancer therapy with interleukin-2: immunologic manipulations can mediate the regression of cancer in humans.

作者信息

Rosenberg S A

机构信息

National Cancer Institute, Bethesda, MD.

出版信息

J Clin Oncol. 1988 Mar;6(3):403-6. doi: 10.1200/JCO.1988.6.3.403.

DOI:10.1200/JCO.1988.6.3.403

PMID:3258361

Abstract

摘要

相似文献

Cancer therapy with interleukin-2: immunologic manipulations can mediate the regression of cancer in humans.白细胞介素-2用于癌症治疗：免疫调控可介导人类癌症的消退。

J Clin Oncol. 1988 Mar;6(3):403-6. doi: 10.1200/JCO.1988.6.3.403.

[Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].[白细胞介素2激活的淋巴细胞（LAK细胞）在肿瘤过继性免疫治疗中的应用]

Pol Tyg Lek. 1988 Nov 21;43(47):1491-5.

Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.利用淋巴因子激活的杀伤细胞和重组白细胞介素-2进行癌症的过继性免疫治疗。

Important Adv Oncol. 1986:55-91.

Immunotherapy of cancer using interleukin 2: current status and future prospects.使用白细胞介素-2进行癌症免疫治疗：现状与未来前景

Immunol Today. 1988 Feb;9(2):58-62. doi: 10.1016/0167-5699(88)91261-3.

Human interleukin 2: molecular biology, physiology and clinical possibilities.人白细胞介素2：分子生物学、生理学及临床应用前景

Immunobiology. 1986 Sep;172(3-5):400-19. doi: 10.1016/S0171-2985(86)80121-8.

[Biological immunomodulators in the treatment of cancer].[生物免疫调节剂在癌症治疗中的应用]

Sangre (Barc). 1988 Apr;33(2):132-43.

[Treatment of malignant tumors by interleukin 2 and LAK cells].白细胞介素2与淋巴因子激活的杀伤细胞治疗恶性肿瘤

Nouv Rev Fr Hematol (1978). 1988;30(1-2):119-22.

"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes.“淋巴因子激活的杀伤细胞”疗法用于人类癌症治疗：基于白细胞介素-2扩增白细胞的实验室研究的临床推断

Prog Clin Biol Res. 1989;288:151-60.

[Adoptive immunotherapy: a new therapeutic approach to cancer based on interleukin 2].[过继性免疫疗法：一种基于白细胞介素-2的癌症新治疗方法]

Rev Med Brux. 1987 Mar;8(3):133-9.

[Interleukin 2].[白细胞介素2]

Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1203-7.

引用本文的文献

Is human cell therapy research caught in a mousetrap?人类细胞治疗研究是否陷入了困境？

Mol Ther. 2011 Feb;19(2):224-7. doi: 10.1038/mt.2010.304.

Gene therapy for urologic cancer.泌尿系统癌症的基因治疗

Curr Urol Rep. 2002 Feb;3(1):75-81. doi: 10.1007/s11934-002-0014-7.

Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro.多种细胞因子对体外白细胞介素-2依赖的黑色素瘤细胞裂解的影响。

Arch Dermatol Res. 1994;286(2):73-6. doi: 10.1007/BF00370730.

Complete remission of liver metastases from colorectal cancer by treatment with a hepatic artery infusion (HAI) of interleukin-2-based immunochemotherapy: reports of three cases.经基于白细胞介素-2的免疫化疗肝动脉灌注（HAI）治疗后，结直肠癌肝转移灶完全缓解：三例报告

Surg Today. 1994;24(1):80-4. doi: 10.1007/BF01676892.

Relevance of the T cell receptor for immunotherapy of cancer.T细胞受体在癌症免疫治疗中的相关性。

Cancer Immunol Immunother. 1994 Jul;39(1):1-14. doi: 10.1007/BF01517174.

Lymphokine activated killer cells.淋巴因子激活的杀伤细胞

Blut. 1989 Oct;59(4):375-84. doi: 10.1007/BF00321208.

Hepatic artery infusion and chemoembolization in the management of liver metastases.肝动脉灌注及化疗栓塞在肝转移瘤治疗中的应用

Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):153-60. doi: 10.1007/BF02575467.

Immunotherapy of glioblastoma with intratumoural administration of autologous lymphocytes and human lymphoblastoid interferon. A further clinical study.采用肿瘤内注射自体淋巴细胞和人淋巴母细胞样干扰素对胶质母细胞瘤进行免疫治疗。进一步的临床研究。

Acta Neurochir (Wien). 1991;109(1-2):42-5. doi: 10.1007/BF01405696.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验